Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S234000
Reexamination Certificate
active
07863298
ABSTRACT:
The present invention is directed to 1α,25-dihydroxyvitamin D3 mimics which modulate the vitamin D receptor (VDR). The invention is further directed to pharmaceutical compositions and methods for the treatment, prevention or amelioration of one or more symptoms of disease or disorder related to the activity of the vitamin D receptor using an effective amount of a compound of formula (I).
REFERENCES:
patent: 4717760 (1988-01-01), Parker et al.
patent: 5210353 (1993-05-01), Udovich et al.
patent: 5710347 (1998-01-01), Nishibori et al.
patent: 6218430 (2001-04-01), Allegretto et al.
patent: 2006/0014811 (2006-01-01), Muto et al.
patent: 2006/0035944 (2006-02-01), Muto et al.
patent: 1328880 (1994-04-01), None
patent: 0438715 (1991-07-01), None
patent: 0285160 (1993-12-01), None
patent: 1095959 (1967-12-01), None
patent: 1 410 275 (1975-10-01), None
patent: 3255067 (1991-11-01), None
patent: WO 03/103655 (2003-12-01), None
patent: WO 03/103657 (2003-12-01), None
patent: WO 2004/048309 (2004-06-01), None
patent: WO 2004/063345 (2004-07-01), None
Shimizu, I. et al.; “Molybdenum-Catalyzed Aromatic Substitution With Olefins and Alcohols”; Chemistry Letters 1997; May 2, 1997; pp. 851-852; The Chemical Society of Japan.
Perera et al. “Synthesis and thermal cyclopolymerization of heterocycle containing bis-ortho-diynyl arenes” Tetrahedron, vol. 58, Issue 51, pp. 10197-10203 (2002).
Sengupta et al. “Synthetic studies on tetraphenylmethane dendrimers” Tetrahedron Letters, vol. 40, Issue 51, pp. 9157-9161 (1999).
Pozdnyakovich et al. “Fluorine-containing carbocations. IV. The use of salt solutions of stable polyfluorinated α,α-difluorobenzyl and α-fluorodiphenylmethyl cations in antimony pentafluoride in the synthesis of polyfluorinated benzoic acids, benzophenones and diphenyldifluoromethanes” Journal of Fluorine Chemistry, vol. 4, Issue 3, pp. 317-326 (1974).
Tam-Chang et al. “Catalytic cylcopropanes. Part IX. A thiazolo-cyclophane as model for pyruvate oxidase and one-pot synthesis of aromatic esters by electrochemical oxidation of aldehydes mediated by bis(coenzyme) catalysis”. Helvetica Chimica Acta, 76(7): 2616-2639 (1993).
Hixson et al. “arlycyclopropane photochemistry. Effects of electron-donating and electron-withdrawing aromatic substituents of the photochemical rearrangement of 1,1-diarylcyclopropanes”. J. Organic Chem. 53(12): 2706-2711 (1988).
Flatt Brenton T.
Martin Richard
Mohan Raju
Murphy Brett
Exelixis Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Solola Taofiq A
LandOfFree
Bridged ring structures as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bridged ring structures as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bridged ring structures as pharmaceutical agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2731007